Health ❯Pharmaceuticals ❯Drug Regulation

FDA

Compounding Pharmacies Compounded Drugs Oral Phenylephrine Tirzepatide Over-the-Counter Medications Oral Decongestants Nasal Decongestants

FDA Moves to Ban Ineffective Cold Medicine Ingredient

The FDA has proposed removing oral phenylephrine from over-the-counter cold medicines, citing ineffectiveness as a nasal decongestant.

FDA Proposes Removal of Ineffective Oral Phenylephrine from Cold Medicines

Novo Nordisk Urges FDA to Ban Compounded Versions of Ozempic and Wegovy